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Background
Our objective is to develop replicating recombinant vesi-
cular stomatitis virus (rVSV) vectored HIV vaccine candi-
dates that deliver membrane-bound trimeric HIV Env in a
functional conformation.
Methods
Using a combination of nucleotide sequence optimization
and protein domain swapping, we have generated a panel
of novel gene inserts for VSV vectors that encode chimeric
HIV-1 and VSV glycoprotein immunogens (EnvG). A
stable VERO cell line engineered to express human CD4
and CCR5 was used to rescue rVSV vectors in which the
G gene was replaced with coding sequence for several
different EnvG proteins.
Results
Analysis of cells transfected with plasmid DNA expressing
EnvG constructs revealed abundant cell surface expression
of chimeric glycoproteins. The expressed proteins retained
CD4-dependent membrane fusion activity, which is one of
the main characteristics of functional HIV Env. The chi-
meric EnvG in which the signal peptide (SP), transmem-
brane (TM) and cytoplasmic tail (CT) domains of HIV
Env were replaced with functionally related domains of
VSV G were expressed efficiently and supported vector
propagation to high titer specifically in CD4+CCR5+ cells.
Flow cytometric analysis demonstrated that cell-surface
expressed EnvG chimeras were recognized by a spectrum
of HIV-1 specific broadly neutralizing monoclonal antibo-
dies, including those that bind preferentially to the tri-
meric spike. Western blot analysis on purified viruses
indicated that EnvG glycoproteins that contained the VSV
G TM and CT were incorporated efficiently into VSV par-
ticles. Interestingly, an EnvG in which the Env MPER
domain was replaced with membrane-proximal sequence
from G was more effectively processed and incorporated
into virus particles.
Conclusion
Chimeric EnvG glycoproteins expressed efficiently from
plasmid DNA and rVSV vectors in membrane-bound,
fusion-competent conformation and displayed relevant
HIV-1 broadly neutralizing antibody epitopes. Small ani-
mal studies are underway to assess Env-specific humoral
immune responses elicited by rVSV vectors encoding
EnvG immunogens.
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